The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties

被引:326
作者
Austin, RP [1 ]
Barton, P [1 ]
Cockroft, SL [1 ]
Wenlock, MC [1 ]
Riley, RJ [1 ]
机构
[1] AstraZeneca R&D Charnwood, Dept Phys & Metab Sci, Loughborough LE11 5RH, Leics, England
关键词
D O I
10.1124/dmd.30.12.1497
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The apparent intrinsic clearance of 13 drugs has been determined using rat liver microsomes at three different concentrations of microsomal protein. The kinetics was studied using the in vitro half-life method. The nonspecific binding of these drugs to the microsomes was also studied under the same conditions, except for cofactor removal, using equilibrium dialysis. The intrinsic clearances are shown to be dependent on the microsomal concentration, but are approximately constant when corrected for the extent of nonspecific binding to the microsomes. The large difference between observed intrinsic clearance and unbound intrinsic clearance that exists for some compounds, particularly lipophilic bases, is highlighted. A simple model has been developed for understanding the binding of compounds to microsomes and is demonstrated to accurately predict the extent of microsomal binding at one concentration of microsomes from measurement at another. The binding of a further 25 drugs to rat liver microsomes at a microsomal concentration of 1 mg/ml was also studied, along with measurements of lipophilicity using octanol-water partition coefficients. It is shown that the extent of microsomal binding is correlated with lipophilicity, but that basic compounds show a different behavior to acidic and neutral compounds. Microsomal binding is shown to be best predicted using a model where logP is used for basic compounds, and logD(7.4) is used for acidic and neutral compounds. This model has been developed further so that the extent of binding to microsomes of any given concentration can be estimated purely from a knowledge of lipophilicity and ionization.
引用
收藏
页码:1497 / 1503
页数:7
相关论文
共 22 条
[1]   PARTITIONING OF IONIZING MOLECULES BETWEEN AQUEOUS BUFFERS AND PHOSPHOLIPID-VESICLES [J].
AUSTIN, RP ;
DAVIS, AM ;
MANNERS, CN .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (10) :1180-1183
[2]  
BAARNHIELM C, 1986, ACTA PHARMACOL TOX, V59, P113
[3]   Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans [J].
Carlile, DJ ;
Hakooz, N ;
Bayliss, MK ;
Houston, JB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (06) :625-635
[4]  
HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469
[5]   Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions [J].
Ishigam, M ;
Uchiyama, M ;
Kondo, T ;
Iwabuchi, H ;
Inoue, S ;
Takasaki, W ;
Ikeda, T ;
Komai, T ;
Ito, K ;
Sugiyama, Y .
PHARMACEUTICAL RESEARCH, 2001, 18 (05) :622-631
[6]   Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data [J].
Iwatsubo, T ;
Hirota, N ;
Ooie, T ;
Suzuki, H ;
Shimada, N ;
Chiba, K ;
Ishizaki, T ;
Green, CE ;
Tyson, CA ;
Sugiyama, Y .
PHARMACOLOGY & THERAPEUTICS, 1997, 73 (02) :147-171
[7]  
Kalvass JC, 2001, DRUG METAB DISPOS, V29, P1332
[8]   Towards the predictability of drug-lipid membrane interactions:: The pH-dependent affinity of propranolol to phosphatidylinositol containing liposomes [J].
Krämer, SD ;
Braun, A ;
Jakits-Deiser, C ;
Wunderli-Allenspach, H .
PHARMACEUTICAL RESEARCH, 1998, 15 (05) :739-744
[9]  
Lavé T, 1999, CLIN PHARMACOKINET, V36, P211
[10]   PARTITION COEFFICIENTS AND THEIR USES [J].
LEO, A ;
HANSCH, C ;
ELKINS, D .
CHEMICAL REVIEWS, 1971, 71 (06) :525-+